Investigational Site Number : 376003

Tel Litwinsky 52621

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Diabetes Mellitus, Type 2, Idiopathic Pulmonary Fibrosis, Multiple Sclerosis, Squamous Cell Lung Cancer

Studies at this site

• Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed
• Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed